healthy individuals
Conditions
Interventions
Euglena Gracilis powder-containing drink
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy infant subjects aged 1 to 6 years (2) Subjects suffering from atopic dermatitis (3) Parents or legal guardians voluntarily volunteer for the subject to participate in the exam after the subject's parents or legal guardians fully understand the purpose and content of this exam
Exclusion criteria
Exclusion criteria: (1) Persons with a history of other diseases that may affect the results of this study, such as liver disease, renal disease, digestive system disease, respiratory disease, heart disease, blood disease, endocrine and metabolism, or surgery History subjects (2) Persons with a disease requiring constant medication, subjects with a history of serious illness requiring medication (3) Subjects with food and drug allergies (4) Subject who routinely ingests functional foods and supplements that may affect the excretion of harmful substances in the body (5) Those who play intense sports and subjects who are on a diet (6) Subjects who have participated in clinical trials or long-term clinical trials of foods and cosmetics within 4 weeks, and subjects who are currently participating in clinical trials (7) Other subjects judged by the investigator to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atopic Dermatitis dermatitis symptoms (subjective and objective parameters) Safety (harmful events, urine items) Bowel status | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical condition Physical examination DHEA-S in saliva Melatonin in saliva Electroencephalogram during sleep Autonomic nerves activities during sleep Attention test Questionnaires (oral cavity, health condition, basic lifestyle, sociality) | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed